Sagar Vidya Nootheti, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4700 Berwyn House Road, Suite 108, College Park, MD 20740 Phone: 301-345-0077 Fax: 301-345-4489 |
News Archive
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral load in vitro.
Personalities and politics swirl around news about Monday's ruling in the Virginia health law challenge, with news outlets detailing how judges in different cases reached their conclusions and examining Judge Henry Hudson's ties to a GOP consulting firm. More reports also surround the related political dust-ups and posturing.
The Boston Globe: A proposed acquisition of Boston's Catholic hospital system Caritas Christi Health Care by private-equity firm Cerberus Capital Management may test the theory that "profitability and religious mission can be integrated." However, another local hospital provides a possible window into that future.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
› Verified 3 days ago